Latest Listings And Ipos News

Fat Prophets Global Contrarian Fund (ASX: FPC) has disclosed the Dividend Reinvestment Plan (DRP) price for its six-month dividend ending December 2025, applying a 2.5% discount to the volume weighted average price, resulting in a DRP price of AUD 1.35 per share.

WhiteHawk Limited has raised A$1.5 million through a share placement to fund integration and growth of its newly acquired Quixxi Clarity AI platform, marking a strategic push into the AI governance market.

National Storage REIT securityholders have overwhelmingly approved the Brookfield-GIC consortium's $2.86 per security cash acquisition, paving the way for a $6.7 billion transaction expected to complete in May 2026.

Haranga Resources has almost finished a 3,270m underground diamond drilling program at its Lincoln Gold Project in California, uncovering visual evidence of gold mineralisation repeating at depth. Assay results and a maiden JORC Mineral Resource Estimate are expected soon, alongside new exploration targets.

icetana AI has landed a US$176,450 SaaS contract through SoftBank Robotics for Japan Reliance Service Corporation, adding around 10% to its annual recurring revenue and highlighting growing demand for AI security in Japan.

Forrestania Resources has revealed further high-grade niobium mineralisation from its maiden RC drilling at the Wozi Project, Malawi, validating a large near-surface system with grades up to 0.94% Nb2O5 and confirming the project's critical minerals potential.

Comvita launches a NZ$30 million renounceable Rights Offer to refinance debt and bring Southeast Asian consumer giant Fraser and Neave onboard as a strategic investor with a near 20% stake.

BlackRock Investment Management has announced estimated cash distributions for its Australian iShares Balanced ESG and High Growth ESG ETFs, with key dates set for mid to late April 2026. Investors have until 15 April to opt into the Distribution Reinvestment Plan.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

Rhythm Biosciences has clarified inconsistencies in its disclosures around termination events in its underwriting agreement for RHYO options, following an ASX query. The company acknowledged an incomplete initial summary and administrative oversights but confirmed the agreement remains in full effect.

The Qualitas Real Estate Income Fund (ASX: QRI) has raised its March 2026 distribution yield to 7.25% annualised, reflecting a completed investment loan on assets needing repositioning amid ongoing high interest rates.

Tarrina Resources (ASX: TR8) has addressed ASX’s query on recent share price movement, confirming it has dispatched soil and drill core samples for laboratory testing with results expected by late April. The company maintains strict confidentiality protocols and affirms compliance with continuous disclosure rules.